Partnership focused on identifying 1-2 strategic investment opportunities per year in companies bringing transformative and commercially scalable solutions to unsolved problems and underserved markets:
- Stage: Up to 12 months prior to major inflection point of rapid growth in value and commercial scale.
- Primary Focus: Life sciences and healthcare companies best positioned to drive or enable rapid transformation to next generation consumer demand & value driven healthcare 2020-2030. Included but not limited to platform companies addressing aging population, inflammation, autoimmune, neurodegeneration, brain health.
- Company Attributes: Leadership position in underserved market; deep understanding of the industry ecosystem and competitive landscape; capacity to attract top talent across all disciplines; culture that embraces technology, data, innovation, and human capital and communication; prepared to scale quickly through operational excellence, acquisitions, partnerships, and/or licensing; commitment to strong governance; the Board, founder, officers, major investors aligned on operating plan and return objectives.
- Investment Approach: Lead or co-lead new investment round, and serve on Board of Directors. Help de-risk final transition to major value and growth inflection point. Support parallel paths to IPO or M&A.